Vaccines Market is Expected to Reach $57.8 Billion by 2019 - New Report by MarketsandMarkets

Share Article

North America dominates the vaccines market with the U.S. accounting for a major market share. http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

MarketsandMarkets

MarketsandMarkets

Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson and Johnson (U.S.), MedImmune, LLC (U.S.), Merck and Company (U.S.)

Major factors driving growth of Vaccines market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development and rising initiatives by non-government organizations for vaccinations. Emerging economies such as India and China present an array of opportunities for this market.

Early buyers will receive 10% customization on reports.
http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

The global vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8% from 2014 to 2019. The Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the vaccines market along with the estimates and forecasts of the revenue and market share analysis.

For Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1155

The report segments this market on the basis of type, technology, disease indication, and end user. Among various end users, the pediatrics segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. Growth in this segment can be attributed to the rising prevalence of diseases and the increasing number of initiatives taken by government organizations for vaccination programs.

For PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1155

Based on geography, the global vaccines market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth of this market is driven by factors such as increasing government support for vaccine development, rising company investments for vaccine research, and high prevalence of diseases.

Key players in the vaccines market include Bavarian Nordic (Denmark), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson and Johnson (U.S.), MedImmune, LLC (U.S.), Merck and Company (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), and Sanofi Pasteur (France).

Browse Related Reports:
Patient Registry Software Market by Delivery Mode (Subscription, Ownership), Functionality (Population Health Management, Point of Care, Care Management), Database (Diabetes, Cancer, Cardiovascular, Chronic & Rare Disease) & by End User - Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/patient-registry-software-market-144694594.html

Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/dermatology-market-154.html

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr.Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
Like >
Follow us on
Visit website